La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Titre (en) » - entrée « factor »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
facteurs < factor < factorial  Facettes :

List of bibliographic references indexed by factor

Number of relevant bibliographic references: 63.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000069 (2017) Nicole L. Bertschi [Suisse] ; Christa G. Toenhake [Pays-Bas] ; Angela Zou [Canada] ; Igor Niederwieser [Suisse] ; Rob Henderson [Pays-Bas] ; Suzette Moes [Suisse] ; Paul Jenoe [Suisse] ; John Parkinson [Canada] ; Richard Bartfai [Pays-Bas] ; Till S. Voss [Suisse]Malaria parasites possess a telomere repeat-binding protein that shares ancestry with transcription factor IIIA.
000113 (2017) Catherine M. Duclos [Canada] ; Audrey Champagne [Canada] ; Julie C. Carrier [Canada] ; Caroline Saucier [Canada] ; Christine L. Lavoie [Canada] ; Jean-Bernard Denault [Canada]Caspase-mediated proteolysis of the sorting nexin 2 disrupts retromer assembly and potentiates Met/hepatocyte growth factor receptor signaling
000209 (2016) Marie L. Jacobs [Canada] ; Yves Dauvilliers [France] ; Erik K. St Louis [États-Unis] ; Stuart J. Mccarter [États-Unis] ; Silvia Rios Romenets [Canada] ; Amélie Pelletier [Canada] ; Mahmoud Cherif [France] ; Jean-François Gagnon [Canada] ; Ronald B. Postuma [Canada]Risk Factor Profile in Parkinson's Disease Subtype with REM Sleep Behavior Disorder.
000210 (2016) Abdul Qayyum Rana [Canada] ; Abdullah A. Mosabbir [Canada] ; Abdul Rehman M. Qureshi [Canada] ; Muhammad Abbas [Canada] ; Mohammad A. Rana [Australie]Restless leg syndrome: a risk factor of higher prevalence of anxiety and depression in Parkinson's disease patients.
000449 (2016) Michael D. Staudt [Canada] ; Andrea R. Di Sebastiano ; Hu Xu ; Mandar Jog ; Susanne Schmid ; Paula Foster ; Matthew O. HebbAdvances in Neurotrophic Factor and Cell-Based Therapies for Parkinson's Disease: A Mini-Review.
000481 (2015) Anja Meissner ; Naomi P. Visanji ; M Abdul Momen ; Rui Feng ; Beverly M. Francis ; Steffen-Sebastian Bolz ; Lili-Naz HazratiTumor Necrosis Factor-α Underlies Loss of Cortical Dendritic Spine Density in a Mouse Model of Congestive Heart Failure
000579 (2015) R T Bartus [États-Unis] ; J H Kordower [États-Unis] ; E M Johnson [États-Unis] ; L. Brown [États-Unis] ; B R Kruegel [États-Unis] ; Y. Chu [États-Unis] ; T L Baumann [États-Unis] ; A E Lang [Canada] ; C W Olanow [États-Unis] ; C D Herzog [États-Unis]Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies.
000670 (2015) Janaina Brusco ; Kurt HaasInteractions between mitochondria and the transcription factor myocyte enhancer factor 2 (MEF2) regulate neuronal structural and functional plasticity and metaplasticity
000830 (2015) J. Jimenez-Pardo [Canada] ; J D Holmes ; M E Jenkins ; A M JohnsonAn Examination of the Reliability and Factor Structure of the Physical Activity Scale for Individuals With Physical Disabilities (PASIPD) Among Individuals Living With Parkinson's Disease.
000A52 (2014) Michèle G. Duval [Canada] ; Matthew J. H. Gilbert [Canada] ; D. Ezekiel Watson [Canada] ; Tanja C. Zerulla [Canada] ; Keith B. Tierney [Canada] ; W. Ted Allison [Canada]Growth Differentiation Factor 6 As a Putative Risk Factor in Neuromuscular Degeneration
000C37 (2013) Kelvin C. Luk [Canada] ; Vladimir V. Rymar ; Pepijn Van Den Munckhof ; Stefan Nicolau ; Claude Steriade ; Panojot Bifsha ; Jacques Drouin ; Abbas F. SadikotThe transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.
000C97 (2013) Matthew P. Mount ; Yi Zhang ; Mandana Amini ; Steve Callaghan ; Jerzy Kulczycki ; Zixu Mao ; Ruth S. Slack ; Hymie Anisman ; David S. ParkPerturbation of Transcription Factor Nur77 Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)*
000D21 (2013) Hu Xu [Canada] ; Louiza Belkacemi ; Mandar Jog ; Andrew Parrent ; Matthew O. HebbNeurotrophic factor expression in expandable cell populations from brain samples in living patients with Parkinson's disease.
000D67 (2013) Valerie Lefebvre ; Qiujiang Du ; Stephen Baird ; Andy Cheuk-Him Ng ; Mirna Nascimento ; Michelangelo Campanella ; Heidi M. Mcbride ; Robert A. ScreatonGenome-wide RNAi screen identifies ATPase inhibitory factor 1 (ATPIF1) as essential for PARK2 recruitment and mitophagy.
000E18 (2013) Kaylena A. Ehgoetz Martens [Canada] ; Frederico Pieruccini-Faria [Canada] ; Quincy J. Almeida [Canada]Could Sensory Mechanisms Be a Core Factor That Underlies Freezing of Gait in Parkinson’s Disease?
000E28 (2013) Hannah Taylor [Royaume-Uni] ; Neil Barua [Royaume-Uni] ; Alison Bienemann [Royaume-Uni] ; Marcella Wyatt [Royaume-Uni] ; Emma Castrique [Royaume-Uni] ; Rebecca Foster [Royaume-Uni] ; Matthias Luz [Canada] ; Christian Fibiger [Canada] ; Erich Mohr [Canada] ; Steven Gill [Royaume-Uni]Clearance and Toxicity of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHu GDNF) Following Acute Convection-Enhanced Delivery into the Striatum
001012 (2013) Indranil Dey [Canada] ; Nisha Midha [Canada] ; Geeta Singh [Canada] ; Amanda Forsyth [Canada] ; Sarah K. Walsh [Canada] ; Bhagat Singh [Canada] ; Ranjan Kumar [Canada] ; Cory Toth [Canada] ; Rajiv Midha [Canada]Diabetic Schwann cells suffer from nerve growth factor and neurotrophin‐3 underproduction and poor associability with axons
001192 (2012) Seungmae Seo ; Gwen Lomberk ; Angela Mathison ; Navtej Buttar ; Jewel Podratz ; Ezequiel Calvo ; Juan Iovanna [France] ; Stephen Brimijoin ; Anthony Windebank ; Raul UrrutiaKrüppel-like Factor 11 Differentially Couples to Histone Acetyltransferase and Histone Methyltransferase Chromatin Remodeling Pathways to Transcriptionally Regulate Dopamine D2 Receptor in Neuronal Cells*
001562 (2011) Hong Wu ; Roger P. LengUBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation
001A17 (2010) Bahareh Behrouz [États-Unis] ; Carles Vilari O-Güell ; Michael G. Heckman ; Alexandra I. Soto-Ortolaza ; Jan O. Aasly ; Sigrid Sando ; Timothy Lynch ; David Craig ; Ryan J. Uitti ; Zbigniew K. Wszolek ; Owen A. Ross ; Matthew J. FarrerMitochondrial translation initiation factor 3 polymorphism and Parkinson's disease.
001A94 (2010) Emmanuelle Pourcher [Canada] ; Sophie Rémillard ; Henri CohenAffect in Parkinson's disease: validation of the two-factor approach.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "factor" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "factor" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    factor
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022